The study by Su et al. identified a total of 16 target genes of curcumin that are relevant to glioblastoma, among which three—ENO1, MMP2 and PRKD2—were found to significantly impact the prognosis of GBM patients (p < 0.05) [190]. The gene discussed is ENO1; the disease is glioblastoma.